Analysis of decisions made in meta-analyses of depression screening and the risk of confirmation bias:A case study by Goodyear-Smith, Felicity A. et al.
Bond University
Research Repository
Analysis of decisions made in meta-analyses of depression screening and the risk of
confirmation bias
Goodyear-Smith, Felicity A.; Van Driel, Mieke L.; Arroll, Bruce; Del Mar, Chris
Published in:
BMC Medical Research Methodology
DOI:
10.1186/1471-2288-12-76
Published: 01/01/2012
Document Version:
Publisher's PDF, also known as Version of record
Link to publication in Bond University research repository.
Recommended citation(APA):
Goodyear-Smith, F. A., Van Driel, M. L., Arroll, B., & Del Mar, C. (2012). Analysis of decisions made in meta-
analyses of depression screening and the risk of confirmation bias: A case study. BMC Medical Research
Methodology, 12, [76]. https://doi.org/10.1186/1471-2288-12-76
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
For more information, or if you believe that this document breaches copyright, please contact the Bond University research repository
coordinator.
Download date: 06 Nov 2019
Goodyear-Smith et al. BMC Medical Research Methodology 2012, 12:76
http://www.biomedcentral.com/1471-2288/12/76RESEARCH ARTICLE Open AccessAnalysis of decisions made in meta-analyses of
depression screening and the risk of confirmation
bias: A case study
Felicity A Goodyear-Smith1*, Mieke L van Driel2,3,4, Bruce Arroll1 and Chris Del Mar4Abstract
Background: Depression is common in primary care and clinicians are encouraged to screen their patients. Meta-
analyses have evaluated the effectiveness of screening, but two author groups consistently reached completely
opposite conclusions.
Methods: We identified five systematic reviews on depression screening conducted between 2001 and 2009, three
by Gilbody and colleagues and two by the United States Preventive Task Force. The two author groups consistently
reached completely opposite conclusions. We analyzed two contemporaneous systematic reviews, applying a
stepwise approach to unravel their methods. Decision points were identified, and discrepancies between systematic
reviews authors’ justification of choices made were recorded.
Results: Two systematic reviews each addressing three research questions included 26 randomized controlled trials
with different combinations in each review. For the outcome depression screening resulting in treatment, both
reviews undertook meta-analyses of imperfectly overlapping studies. Two in particular, pooled each by only one of
the reviews, influenced the recommendations in opposite directions. Justification for inclusion or exclusion of
studies was obtuse.
Conclusion: Systematic reviews may be less objective than assumed. Based on this analysis of two meta-analyses
we hypothesise that strongly held prior beliefs (confirmation bias) may have influenced inclusion and exclusion
criteria of studies, and their interpretation. Authors should be required to declare a priori any strongly held prior
beliefs within their hypotheses, before embarking on systematic reviews.
Keywords: Meta-analysis, Meta-Analysis as Topic, Bias (Epidemiology), Methods, Depression, Mass screening, Social
values, Confirmation biasBackground
Meta-analyses of randomized controlled or N-of-1 trials
provides us with the highest level of evidence to inform
guidelines and clinical practice. Their validity is there-
fore important. Over the past 20 years their method-
ology [1-3] and reporting has been improved. This
includes establishing the PRISMA (Preferred Reporting
Items for Systematic Reviews and Meta-Analyses) state-
ment (http://www.prisma-statement.org/), which has
increased their rigor and transparency. Despite this,* Correspondence: f.goodyear-smith@auckland.ac.nz
1Department of General Practice & Primary Health Care, University of
Auckland, PB 92019, Auckland 1142, New Zealand
Full list of author information is available at the end of the article
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Creative Commons Attribution License (http:/
distribution, and reproduction in any mediumhowever, meta-analyses addressing the same research
question arrive at conflicting conclusions or recommen-
dations. The reasons have been explored [4-7]. They in-
clude numerous decision points in the review process –
such as which study to include or exclude; the risk of
bias assessment; and which data to extract. Even within
the constraints of a strict protocol, subjective decisions
are made.
In this example, we study two different author groups’
meta-analyses of trials investigating the effectiveness of
screening for depression, which arrived at opposing
recommendations, (one supporting screening and an-
other questioning it) [8-10], in spite of identical research
questions.d Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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or other of the possible recommendations, so called
‘confirmation bias’: if an investigator approaches any
question with a strong prior belief, their approach to
answering that question may be biased [11].
We aim to explore how meta-analyses with the same re-
search question can have opposing recommendations, using
a case study approach to examine the decision-points.
Methods
We chose this example because we were aware of the
startling discrepancies in recommendations from differ-
ent reviews addressing the question. A search was con-
ducted for all systematic reviews and meta-analyses on
screening for depression in primary care using the data-
bases MEDLINE, EMBASE,CINAHL, PsycLIT and the
Cochrane Database of Systematic Reviews, and hand-
searching of the relevant reference lists.
The objectives, findings and conclusions of all accessed
reviews were compared (Table 1). Two meta-analyses
were selected for in depth exploration of the review
process. Subsequently, two authors (FGS and MLvD) ap-
plied a stepwise approach to unravel the review process
followed by the authors of the selected meta-analyses.
Each decision moment in the analysis process was
recorded alongside an appreciation of the decisions
reported by the authors of the selected meta-analyses.
Discrepancies between the authors of this study and the
justification of choices made were recorded. The two
other authors of this paper commented on consistency
and transparency of the recorded process and findings.
The individual randomized controlled trials (RCTs)
included in each review were identified, accessed and
examined. A table was constructed recording for each
RCT the sample size of the trial, whether or not it
favored screening, whether it was included and whether
it was pooled in each of the reviews (Table 2). The
various decisions the authors of the two meta-analyses
had made regarding which outcomes to analyze and
their data extractions from original studies were
explored.
Results
The results of our explorative analysis are presented in
the flowchart (Figure 1). Five systematic reviews (four
with pooled data) were identified. Three meta-analyses
were conducted by Gilbody and colleagues between
2001 and 2008, including one Cochrane review [8-10].
None of these favoured screening. Two reviews (one
meta-analysis) from another author group, the US Pre-
ventative Task Force (USPTF), in 2002 [12,13] and 2009
[14,15] favoured screening (Table 1).
The five reviews included a total of 26 RCTs [16-41]
and not one of these was included in all reviews(Table 2). For example, for the outcome of providing
practitioners with feedback on screening (detection of
possible depression) prior to initiation of treatment, Gil-
body 2001 [10] pooled four RCTs [17,21-23] whereas for
the same outcome the USPTF pooled a completely dif-
ferent set of seven RCTs.[20,26,27,30,31,33,34] All of
these studies would have been available to both author
groups with the exception of the study by Wells [33],
which might not have been published when Gilbody
et al. conducted their search.
Each of the five reviews considered three different re-
search questions (effectiveness on detection, treatment
and patient outcomes) with different combinations of
RCTs included for each. Again, none of these were com-
mon between reviews. This meant that there were 15
different combinations of RCTs for the five reviews con-
sidering the three research questions. For pragmatic rea-
sons we decided to select two reviews with opposing
recommendations which addressed the same research
question to determine factors leading to discrepant
findings.
The two meta-analyses we selected for comparison,
one favouring and the other not favouring screening
were the Cochrane review by Gilbody of 2005 [8] and
the USPTF 2002 meta-analysis [13]. These two meta-
analyses contained the most information on both
included and excluded trials, had the most overlapping
studies and both included pooled data. We decided to
focus on only one of the three research questions
addressed in the meta-analyses. The outcome of the ef-
fect of depression screening on treatment (i.e. if the pa-
tient received treatment for depression) was selected
because this is of clinical importance and also included
the largest number of studies used in the reviews. We
identified RCTs included and pooled in either review
and then examined these to determine which most influ-
enced the results favouring screening or not screening.
We found that the opposing recommendations of the
two reviews were largely determined by the Lewis study
[27] pooled in the Cochrane but not the USPTF review,
and the Wells trial [33] pooled in the USPTF but
excluded from the Cochrane review.
On inspection of the forest plot in the Cochrane re-
view for the outcome of management of depression fol-
lowing feedback (prescription of anti-depressants) [8]
(their Analysis 2.2, p 28), the Lewis study [27] has the
greatest weighting (37.5%). It can be seen clearly that
this study shifts the plot from favoring screening to
favoring not screening. The USPTF included this study
in their review but did not pool it for this outcome be-
cause they report that the figures “cannot be calculated
from available data”. There were 227 patients in each of
the control and screened arms. The Cochrane review
has entered the Lewis study in their forest plot as 100/
Table 1 Comparison of research objectives, findings and conclusions in five reviews
Reference Objective Findings Conclusion
Gilbody, 2001
[10]
To examine the effect of routinely
administered psychiatric
questionnaires on the:
1. Meta-analytic pooling of 4 studies
(2457 participants) which measured the
effect of feedback on the recognition of
depressive disorders found that routine
administration and feedback of scores
for all patients did not increase the
overall rate of recognition of mental
disorders such as anxiety and depression.
The routine administration of psychiatric
questionnaires with feedback to
clinicians does not improve the
detection of emotional disorders or
patient outcome, although those
with high scores may benefit.
1. recognition, 2. 2 studies showed that routine
administration followed by selective
feedback for only high scorers increased
the rate of recognition of depression.
The widely advocated use of simple
questionnaires as outcomes measures
in routine practice is not supported.
2. management, and 3. This increased recognition did not
translate into increased rate of intervention.
3. outcome of psychiatric disorders
in nonpsychiatric settings
4. Overall, studies of routine
administration of psychiatric measures
did not show an effect on patient
outcome.
Gilbody,
2005 [8]
To determine the clinical
effectiveness of screening and
case finding instruments
in improving depression:
1. According to case note entries
of depression, screening/case
finding instruments had borderline
impact;
There is substantial evidence that
routinely administered case
finding/screening questionnaires
for depression have minimal impact
on the detection, management or
outcome of depression by clinicians.
1. recognition 2. Overall trend to showing a
borderline higher intervention rate
amongst those who received
feedback of screening/case finding
instruments. This result was
dependent upon presence of
1 highly positive study;
2. management 3. 3 out of 4 studies reported no
clinical effect at either 6 or 12 months.
3. outcome.
Gilbody,
2008 [9]
To establish the effectiveness
of screening in improving the
1. Use of screening or case-finding
instruments were associated with a
modest increase in the recognition
of depression by clinicians
If used alone, case-finding or screening
questionnaires for depression appear to
have little or no impact on the detection
and management of depression by
clinicians.
1. recognition of depression, 2. Questionnaires, when administered to
all patients and the results given to
clinicians irrespective of baseline score,
had no impact on recognition.
Recommendations to adopt screening
strategies using standardized
questionnaires without organizational
enhancements are not justified.
3. There was no evidence of influence on the
prescription of antidepressant medications.
2. the management of depression
and
4. No evidence of an effect on
outcomes of depression was found.
3. the outcomes of patients
with depression.
USPTF, 2002
[12,13]
1. What is the accuracy of
case-finding instruments for
depression in primary
care populations?
1. Compared with usual care,
feedback of depression screening
results to providers generally
increased recognition of depressive
illness in adults.
Compared with usual care, screening
for depression can improve outcomes,
particularly when screening is coupled
with system changes that help ensure
adequate treatment and follow-up.
2. Is treatment of depression in
primary care patients effective in
improving outcomes?
2. Studies examining the effect of
screening and feedback on treatment
rates and clinical outcomes had mixed
results. Many trials lacked power to
detect clinically important differences
in outcomes.
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Table 1 Comparison of research objectives, findings and conclusions in five reviews (Continued)
3. Is routine systematic
identification with case-finding
questions (screening), with or
without integrated management
and follow-up systems, more
effective than usual care in
identifying patients with
depression, facilitating treatment
of patients with depression, and
improving clinical outcomes?
3. Meta-analysis suggests that
overall, screening and feedback
reduced the risk for persistent
depression.
4. Programs that integrated interventions
aimed at improving recognition and
treatment of patients with depression
and that incorporated quality
improvements in clinic systems had
stronger effects than programs
of feedback alone.
USPTF,
2009[14,15]
To review the benefits and harms
of screening adult patients for
depression in a primary care
setting
1. Primary care depression screening and care
management programs with staff assistance,
such as case management or mental health
specialist involvement, can increase
depression response and remission.
1. The USPSTF recommends screening
adults for depression when staff-assisted
depression care supports are in place to
assure accurate diagnosis, effective
treatment, and follow-up. (Grade B
recommendation)
2. Benefit was not evident in screening
programs without staff assistance
in depression care.
2. The USPSTF recommends against
routinely screening adults for depression
when staff-assisted depression care
supports are not in place. There may be
considerations that support screening for
depression in an individual patient.
(Grade C recommendation)
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how they have derived these numbers. The Cochrane re-
view states that for the Lewis study they used published
data only [8]. The Lewis study reports that the mean
number of psychotropic drug prescriptions for the con-
trol arm was 0.44 (SD 1.58) and for the screened arm
was 0.55 (SD 1.43) with a p value of 0.6 (their Table 5)
[27]. However the mean number of drugs prescribed
does not necessarily equate to the proportion of patients
taking psychotropic drugs. Our own attempts to contact
the authors of the Lewis paper to obtain their data have
been unsuccessful to date.
The RCT in the USPTF review [13] which has the great-
est weighting and clearly influences the finding favouring
towards screening is the Wells study.[33] This study en-
rolled 1356 patients who were screened as depressed using
the “stem” items for major depressive and dysthymic dis-
orders from the Composite International Diagnostic Inter-
view (CIDI) [33]. Randomization was by clinic which
either provided usual care (provider not informed that
their patients were in the trial) or provided a quality im-
provement program with either psychotropic medication
or psychological intervention (providers notified that their
patients had screened positive for depression). The quality
of care, mental health outcomes and retention of employ-
ment of depressed patients improved in the intervention
group. The Wells study is excluded from the Cochranereview because it is a “Complex quality improvement
programme” (Characteristics of excluded studies, p22) [8].
Discussion
What initially presented as a straightforward task
revealed itself to be increasingly complex when we dis-
covered that in the five reviews each considering three
outcomes, there were 15 different combinations of
RCTs. Our analysis of the process of two meta-analyses
that address the same research question but reach
contradictory conclusions demonstrates how decisions
in the meta-analysis process can shape the conclusion.
This is an important finding as evidence-based clinical
guidelines and practice recommendations rely on evi-
dence from systematic reviews and meta-analyses.
Two questions come to mind; “Who is right?” and,
“What drove the decisions?" The second question is the
most essential one that requires full attention from
meta-analysts. Addressing the fundamental issue of
human choices in a methodologically rigorous process
might even make an answer to the first and most intui-
tive question superfluous.
There is ample literature on the impact of publication
bias, referring to an overrepresentation of trials with a
‘positive’ outcome in searches, on the conclusions of
meta-analyses [4,42]. This type of bias can be addressed
by searching for unpublished data or extending the
Table 2 Comparison of trials included and pooled in 5 systematic reviews of depression screening
Reference N Favors
screening
Gilbody,
2001 [10]
Gilbody,
2005 [8]
Gilbody,
2008 [9]
USPTF, 2002
[12,13]
USPTF, 2009
[14,15]
Search date 2000 2004 2007 2001 2007
Incl Pool Incl Pool Incl Pool Incl Pool Incl Pool
Johnstone, 1976 [16] 1093 ++ yes no no no yes no yes no yes no
Moore, 1978 [17] 212 + yes yes yes yes yes yes yes no yes no
Linn, 1980 [18] 150 + yes no yes yes yes yes yes no yes no
Zung & Magill, 1983 [19] 143 ++ no no yes no yes no no no yes no
Zung & King, 1983 [20] 49 ++ no no no no no no yes yes no no
Hoeper, 1984 [21] 1452 - yes yes yes yes yes yes no no no no
German, 1987 [22] 488 + yes yes yes yes yes yes no no no no
Magruder-Habib, 1990 [23] 100 ++ yes yes yes yes yes yes yes no yes no
Callahan, 1994 [24] 175 no no yes yes yes no yes yes yes no
Dowrick, 1995 [25] 179 - yes no yes yes yes yes yes no yes no
Callahan, 1996 [26] 222 - no no no no yes yes yes yes yes no
Lewis, 1996 [27] 681 + yes no yes yes yes yes yes yes yes no
Mazonson, 1996 [28] 573 ++ yes no no no no no no no no no
Reilfer, 1996 [29] 358 + no No no no no no yes no no no
Williams, 1999 [30] 969 + no no yes yes yes yes yes yes yes no
Katzelnick, 2000 [31] 407 ++ no no no no no no yes yes yes no
Weatherall, 2000 [32] 100 - no no yes yes yes yes no no no no
Wells, 2000 [33] 1356 ++ no no no no no no yes yes yes no
Whooley, 2000 [34] 331 - no no yes yes yes yes yes yes yes no
Rost, 2001 [35] 479 ++ no no no no no no yes no yes no
Schriger, 2001 [36] 218 - no no no no yes yes no no no no
Christensen, 2003 [37] 1785 + no no no no yes yes no no no no
Jarjoura, 2004 [38] 61 ++ no no no no no no no no yes no
Bergus, 2005 [39] 51 - no no no no yes yes no no no no
Bosmans, 2006 [40] 145 - no no no no no no no no yes no
Rubenstein, 2007 [41] 792 + no no no no no no no no yes no
N= Total number in the trial at baseline (control and intervention arms).
Incl = Included for any or all of three outcomes (recognition, management, outcome of depression).
Pool = Pooled for any or all of three outcomes (recognition, management, outcome of depression).
Cells shaded where study was not available for review with that search date.
USPTF =US Preventive Task Force.
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not clear if this is worth the effort [43].
Discrepancies in outcomes of meta-analyses have been
documented and are often attributed to selective inclu-
sion of studies [5,44,45]. Felson describes a model for
bias in meta-analytic research identifying three stages at
which bias can be introduced: finding studies, selection
of studies to include and extraction of data.[46]. He
argues that “selection bias of studies [as opposed to se-
lection bias of individuals within studies] is probably the
central reason for discrepant results in meta-analyses.”
Cook et al. determined that discordant meta-analyses
could be attributed to “incomplete identification ofrelevant studies, differential inclusion of non-English lan-
guage and nonrandomized trials, different definitions ..,
provision of additional information through direct corres-
pondence with authors, and different statistical methods”
[47]. Another study of eight meta-analyses found “many
errors in both application of eligibility criteria and di-
chotomous data extraction” [48].
While selection bias and differing data extraction may
contribute to discrepancy, our study suggests that the
bias begins before these steps. Over three research ques-
tions in five different reviews, we found 15 different sets
of RCTs were included, yet one author group consist-
ently found against while the other found for screening.
Elements Choice Rationale
KEY: SR = Systematic review RQ = Research question RCT= Randomised controlled trial
Gilbody
2001
Gilbody
2005 2008
Gilbody USPTF 
2002
USPTF 
2009
RCT Lewis RCT Wells
20001996
Depression
screeningDecision point
Decision point
Decision point
Decision point
Decision point
Topic of SR
5 SRs
26 RCTs
RQ1
Diagnosis
RQ2
Treatment
RQ3
Outcome
Include all
Treatment
1 SR per
author group
Largest study
pooled in 1
not other
Knowledge of 
conflicting 
recommendations
Identify 
discrepancies
- Clinically 
important
- Contrasting 
recommendations
-Info on incl / excl
- Pooling
Weighs most in 
pool estimates
Figure 1 Flowchart of decision points and rationale for choices when comparing contrasting systematic reviews.
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other’s earlier publication this does not appear to have
prevented the discrepancies. Which studies are included
and which data from these studies are used involves nu-
merous decisions. To our knowledge, the issue of
choices and decision making in the process of meta-
analysis has not been studied empirically before.
The methodology of meta-analysis is well developed
and is continuously being refined to address identified
threats of bias. The process is well documented in nu-
merous text books, of which the Cochrane Collabor-
ation Reviewers’ Handbook [2] may be the most
widely used. The Cochrane Collaboration, the largest
database of systematic reviews and meta-analyses of
clinical trials in medicine, requires its authors to pro-
duce a protocol describing the intended process of the
review before embarking on the review. Each step is
peer reviewed and monitored by editorial groups, en-
suring methodological rigor. But no matter how rigor-
ously we describe each step in the process, human
decisions are being made all the time. When docu-
menting each decision we made in our exploration, we
ourselves, although experienced reviewers, were aston-
ished by the number of decision moments that oc-
curred. Moreover, some of these decisions could be
traced to ‘subjective’ inclinations. For example, our
choice to explore the question related to effect ofscreening on number of patients on treatment, was
based on a compromise of the desire to study a clinic-
ally relevant question and at the same time have
enough material for further study. Documenting each
of these decisions and the rationale for the choices
could add transparency to the process.
However, there might be an even more fundamental
implicit source of “bias” embedded in the review process.
The consistent findings of the two author groups sug-
gests this. We hypothesise that authors may have a belief
of what the outcome of their meta-analysis will be before
they start, and that this belief may guide choices that are
made on the way which may impact the review's results.
This is a form of confirmation bias [49,50].
This could be an important first form of bias in the
complex decision process of a meta-analysis. It refers to
the fact that authors or researchers seek or interpret evi-
dence in ways that fit with (their own) existing beliefs,
expectations, or hypothesis [49]. Confirmation bias has
many different aspects according to the context in which
it is analysed and been shown to play a role in clinical
decision making [50], but to our knowledge it has not
been applied to risk of bias assessment of meta-analyses.
Unravelling this concept and making its impact explicit
in the meta-analysis process could contribute to a better
understanding of (often implicit) forms of bias that
guide the reviewers’ choices along the way.
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opposing recommendations with important conse-
quences which might be reflected in clinical guidelines,
as is the situation in our case, where the US guidelines
recommended screening but the UK ones recommended
not screening. We recommend that guideline writers
and health policy makers should check all available sys-
tematic reviews to ensure such discrepancies do not
exist. Where contradicting reviews are found guideline
writers should address these discrepancies and justify
any stand they take, not make a subjective decision to
suit their own pre-conceived beliefs. This is where prior
disclosure of belief of what the outcome will be would
be of assistance.
The main limitation of our study is that we chose to
compare only two meta-analyses from the many options
available and we have introduced subjectivity by the
choices we made. However, making these choices and
their potential subjectivity explicit is the main strength
of the study. Our proposal of confirmation bias to ex-
plain the dissonance can only be a hypothesis. It requires
further study, comparing and unravelling decision points
in other meta-analyses .Conclusion
No meta-analysis is value-free. PRISMA involves a 27-
item check list (http://www.prisma-statement.org/), and
expanding this would not solve the problem of con-
firmation bias. Nevertheless, we were surprised at the
number of decision points in a meta–analysis, and
propose an additional step of recognising each decision
point and being explicit about these choices and their
rationale would greatly increase the transparency of the
meta-analysis process. But a better improvement in
transparency of meta-analysis could perhaps be
achieved by asking authors to declare their belief of
the outcome before they embark on the review process.
This step can easily be built into the review process of
the Cochrane Collaboration, where the review protocol
precedes publication of the full review. The implicit
“subjectivity” of the seemingly “objective” meta-analysis
process deserves attention in all published reviews and
is an important part of well-informed evidence-based
practice.Competing interests
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